• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
LTP 1.27% $1.17

LTR PHARMA LIMITED - Discussion

LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The... LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on holistically improving men’s health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction (ED). Its lead product SPONTAN is set apart from existing ED therapies by its mechanism of action-intranasal delivery technology of a PDE5 inhibitor. The nasal cavity is a highly vascular part of the body supporting even and rapid absorption of the drug, empowering it to work in 10 minutes or less. SPONTAN (SDS-089) is a novel intranasal drug (PDE5) delivery platform for Erectile Dysfunction. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Forum Tag Subject View Poster Comments Created with Sketch. Views Created with Sketch. Likes Created with Sketch. Date Created with Sketch.
(20min delay)
Last
$1.17
Change
-0.015(1.27%)
Mkt cap ! $150.0M
Open High Low Value Volume
$1.19 $1.19 $1.17 $340.3K 288.9K

Buyers (Bids)

No. Vol. Price($)
1 11780 $1.17
 

Sellers (Offers)

Price($) Vol. No.
$1.18 12898 2
View Market Depth
Last trade - 16.10pm 03/12/2024 (20 minute delay) ?
Last
$1.17
  Change
-0.015 ( 1.45 %)
Open High Low Volume
$1.19 $1.19 $1.16 105365
Last updated 15.57pm 03/12/2024 ?
LTP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.